Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nephros Inc (NEPH)
NASDAQ:NEPH
Holding NEPH?
Track your performance easily
NEPH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.36 - $4.04
Previous Close$1.59
Volume15.30K
Average Volume (3M)10.16K
Market Cap
$16.24M
Enterprise Value$13.78M
Total Cash (Recent Filing)$2.46M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.94
Next Earnings
Feb 26, 2025EPS Estimate
-$0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding10,544,225
10 Day Avg. Volume5,426
30 Day Avg. Volume10,162
Standard Deviation0.18
R-Squared0.12
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)2.06
Price to Sales (P/S)1.20
Price to Cash Flow (P/CF)-6.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.02
Enterprise Value/Gross Profit1.64
Enterprise Value/Ebitda-17.83
Forecast
1Y Price Target
$4.75Price Target Upside216.67% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Nephros News
PremiumCompany Announcements
Nephros, Inc. Reports First Profitable Quarter in 2024
PremiumCompany Announcements
Nephros Shares 2024 Corporate Outlook and Plans
PremiumCompany Announcements
Nephros Inc to Present Corporate Strategies at Showcase
Ownership Overview
37.20% Insiders
2.57% Mutual Funds
36.26% Other Institutional Investors
22.00% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
NEPH FAQ
What was Nephros Inc’s price range in the past 12 months?
Nephros Inc lowest stock price was $1.36 and its highest was $4.04 in the past 12 months.
What is Nephros Inc’s market cap?
Currently, no data Available
When is Nephros Inc’s upcoming earnings report date?
Nephros Inc’s upcoming earnings report date is Feb 26, 2025 which is in 96 days.
How were Nephros Inc’s earnings last quarter?
Nephros Inc released its earnings results on Nov 07, 2024. The company reported $0.02 earnings per share for the quarter, beating the consensus estimate of -$0.02 by $0.04.
Is Nephros Inc overvalued?
According to Wall Street analysts Nephros Inc’s price is currently Undervalued.
Does Nephros Inc pay dividends?
Nephros Inc does not currently pay dividends.
What is Nephros Inc’s EPS estimate?
Nephros Inc’s EPS estimate is -$0.02.
How many shares outstanding does Nephros Inc have?
Nephros Inc has 10,544,225 shares outstanding.
What happened to Nephros Inc’s price movement after its last earnings report?
Nephros Inc reported an EPS of $0.02 in its last earnings report, beating expectations of -$0.02. Following the earnings report the stock price went up 3.871%.
Which hedge fund is a major shareholder of Nephros Inc?
Among the largest hedge funds holding Nephros Inc’s share is Wexford Capital LP. It holds Nephros Inc’s shares valued at 6M.
---
Nephros Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.75 (216.67% Upside)
$4.75 (216.67% Upside)
Hedge Fund Trend
Increased
By 441.0 Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.10%
12-Months-Change
Fundamentals
Return on Equity
-11.06%
Trailing 12-Months
Asset Growth
-4.88%
Trailing 12-Months
Company Description
Nephros Inc
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Renal Products segment comprises of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.
---
NEPH Earnings Call
Q3 2024
0:00 / 0:00
---
NEPH Stock 12 Month Forecast
Average Price Target
$4.75
▲(216.67% Upside)
Technical Analysis
Best Analysts Covering NEPH
1 Year
1 Year Success Rate
8/23 ratings generated profit
1 Year Average Return
-10.87%
reiterated a buy rating 14 days ago
Copying Anthony Vendetti's trades and holding each position for 1 Year would result in 34.78% of your transactions generating a profit, with an average return of -10.87% per trade.
---